Artal Group S.A.
CIK 1053906
13F filing for Q2 2026・No. 2,691
- Holdings
- US$931.12M
- Quarter change
- −US$79.46M
- Entries
- 2
- Net bought (estimate)
- −US$186.43M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 0
- Sold out 0
- Cut 1
- Added 1
- Corporate actions 0
- Unchanged 0
Largest holdings
2 stocks worth US$931.12M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| CAVACava Group IncCOM | Cut | 6,507,990 | US$510.75M | 54.85% |
| Lexicon Pharmaceuticals IncCOM NEW | Added | 175,156,062 | US$420.37M | 45.15% |
Sign in (free) to see its 2 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 13, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.